Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

LivaNova (LIA) Stock Price & Analysis

4 Followers

LIA Stock Chart & Stats

€82.00€2.00(2.50%)
At close: 5:30 PM GMT+1
€67.5€70€72.5Aug 5Sep 1Sep 2Sep 14Oct 19Nov 2
Day’s Range
EUR 82.00 - EUR 82.00
52-Week Range
EUR 43.80 - EUR 82.50
Previous Close
EUR 80.00
Volume
N/A
Average Volume (3M)
10
Market Cap
EUR 4.52B
Enterprise Value
EUR 4.18B
Total Cash (Recent Filing)
EUR 563.50M
Total Debt (Recent Filing)
EUR 347.90M
Price to Earnings (P/E)
25.4
Beta
0.60
Next Earnings
Feb 24, 2027 (Est.)
EPS Estimate
0.87
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Broad-based Revenue Growth

Double-digit quarterly growth across cardiopulmonary and epilepsy indicates broad commercial traction rather than dependence on one product or region. Raised full-year guidance supports the view that demand, execution, and market access can sustain healthy revenue expansion over the next several quarters.

Oxygenator Market Share And Capacity

Meaningful share gains in a mature market, combined with demand exceeding supply, point to a strengthening competitive position. Added manufacturing capacity and the Thermo Fisher component agreement can help convert backlog into durable revenue growth and support further share gains.

Neuromodulation Clinical Value

Long-term clinical evidence and improved reimbursement strengthen the value proposition for VNS therapy among physicians, patients, and providers. Better outcomes and economics can expand procedure volumes, improve adoption, and reinforce the neuromodulation business over the medium term.

Bears Say

Earnings Volatility

The return to profitability is encouraging, but repeated swings between losses and profits reduce confidence that current margins are fully durable. Uneven earnings history makes forecasting more difficult and raises the risk that future operating performance will be less consistent than recent results suggest.

Cash Conversion And Investment Burden

Positive cash generation supports the business, but weaker conversion of accounting earnings into free cash flow limits internally funded flexibility. Higher spending on capacity, digital health, and infrastructure may create future growth, while also weighing on cash returns and near-term financial resilience.

OSA Reimbursement Uncertainty

The OSA opportunity depends partly on reimbursement clarity, yet coding changes are not final and the expected effective date is distant. This can delay patient access, provider adoption, and revenue scaling, leaving an important growth initiative exposed to policy and market-access uncertainty.

LivaNova News

LIA FAQ

What was LivaNova’s price range in the past 12 months?
LivaNova lowest stock price was €43.80 and its highest was €82.50 in the past 12 months.
What is LivaNova’s market cap?
LivaNova’s market cap is €4.52B.
When is LivaNova’s upcoming earnings report date?
LivaNova’s next earnings report is estimated for Feb 24, 2027 (not yet confirmed), which is in 103 days.
How were LivaNova’s earnings last quarter?
LivaNova released its earnings results on Nov 04, 2026. The company reported €1.101 earnings per share for the quarter, beating the consensus estimate of €0.949 by €0.152.
Is LivaNova overvalued?
According to Wall Street analysts LivaNova’s price is currently Undervalued.
Does LivaNova pay dividends?
LivaNova does not currently pay dividends.
What is LivaNova’s EPS estimate?
LivaNova’s EPS estimate is 0.87.
How many shares outstanding does LivaNova have?
LivaNova has 55,086,807 shares outstanding.
What happened to LivaNova’s price movement after its last earnings report?
LivaNova reported an EPS of €1.101 in its last earnings report, beating expectations of €0.949. Following the earnings report the stock price went down -0.704%.
Which hedge fund is a major shareholder of LivaNova?
Hedge funds hold LivaNova shares: the largest hedge-fund position in LivaNova is 1,137,224,006 shares, and hedge funds decreased their holdings by 210.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology